Exelixis (EXEL) Non-Current Deffered Revenue (2010 - 2023)

Exelixis (EXEL) recorded quarterly Non-Current Deffered Revenue of $6.7 million in Q2 2023, up 6.75% quarter-over-quarter from $6.3 million in Q1 2023, and down 6.73% on a YoY basis from $7.2 million in Q2 2022.

Exelixis (EXEL) Non-Current Deffered Revenue (2010 - 2023) Analysis & Trends

Exelixis' Non-Current Deffered Revenue history runs 11 years deep, the most recent figure standing at $6.7 million for Q2 2023.

  • In Q2 2023, Non-Current Deffered Revenue fell 6.73% year-over-year to $6.7 million; the TTM figure through Jun 2023 stood at $6.7 million (down 6.73% YoY), while the FY2022 annual figure was $6.6 million, down 24.68% from the prior year.
  • Non-Current Deffered Revenue was $6.7 million for Q2 2023 at Exelixis, up from $6.3 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $16.6 million in Q2 2019 to a low of $3.8 million in Q1 2021.
  • Historically, Non-Current Deffered Revenue has averaged $9.3 million across 5 years, with a median of $8.4 million in 2019.
  • The sharpest annual moves came in 2019 and 2020: Non-Current Deffered Revenue jumped 579.01% in 2019, then sank 58.51% in 2020.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $15.4 million in 2019, then slumped by 39.47% to $9.3 million in 2020, then slipped by 6.25% to $8.7 million in 2021, then fell by 24.68% to $6.6 million in 2022, then rose by 2.16% to $6.7 million in 2023.
  • The last three Non-Current Deffered Revenue figures came in at $6.7 million (Q2 2023), $6.3 million (Q1 2023), and $6.6 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 Exelixis 13.72 Bn 12.95 Bn 590.86 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 6.72 Mn
Mar 31, 2023 6.30 Mn
Dec 30, 2022 6.58 Mn
Sep 30, 2022 6.49 Mn
Jul 1, 2022 7.21 Mn
Apr 1, 2022 8.04 Mn
Dec 31, 2021 8.74 Mn
Oct 1, 2021 9.44 Mn
Jul 2, 2021 8.58 Mn
Apr 2, 2021 9.76 Mn
Jan 1, 2021 3.76 Mn
Oct 2, 2020 9.32 Mn
Jul 3, 2020 15.00 Mn
Apr 3, 2020 14.13 Mn
Jan 3, 2020 6.60 Mn
Sep 27, 2019 15.40 Mn
Jun 28, 2019 16.63 Mn
Mar 29, 2019 8.32 Mn
Dec 28, 2018 15.90 Mn
Sep 28, 2018 2.27 Mn